Delivery Order SPE2DB24D2205-SPE2DB25FEGMY
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,523.07 on August 8, 2025, for Mounjaro 7.5 mg/0.5 ml pen injections. This contract represents a firm fixed price delivery order with no set-aside designation, issued competitively under the agency's pharmaceutical procurement framework. The order is scheduled for completion by August 11, 2025, and will be fulfilled from the contractor's Conshohocken, Pennsylvania facility. This delivery order is issued...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $5,758.57 firm fixed-price delivery order on August 14, 2025, for Mounjaro 2.5 mg/0.5 mL pen injections, with an ultimate completion date of August 15, 2025. The contract, issued without set-aside designation, represents a competitively awarded procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a $20,113.77 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pen injections (0.5 ml). The contract is set to be completed by July 31, 2025, with performance occurring at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This competitively awarded delivery order represents a single transaction under AmerisourceBergen's larger pharmaceutical supply agreement with...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,162.70 for Mounjaro 7.5 mg/0.5 ml pen auto-injectors on July 23, 2025, with completion targeted for July 24, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control, representing part of the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pen injections with a ceiling value of $20,300.82. This is a firm fixed-price delivery order with no set-aside designation, classified as a competitive award. The order is scheduled for ultimate completion by August 8, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major...
- The Defense Logistics Agency awarded a $2,468.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injections on August 12, 2025, with an ultimate completion date of August 13, 2025. This is an unset-aside, competitively awarded contract with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $6,045.27 delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pen injections on August 13, 2025, with completion targeted for August 14, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication, consistent with AmerisourceBergen's established portfolio of...
- The Defense Logistics Agency awarded a $33,391.18 delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors on August 18, 2025, with an ultimate completion date of August 19, 2025. This is a firm fixed price, non-set-aside contract performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pen injections with a ceiling value of $1,571.57. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award to support federal medical procurement needs. The contract is set to complete by August 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $19,548.95 for Mounjaro 7.5 mg/0.5 mL pen injectors on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEGMYDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injections valued at $10,119.18. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 21, 2025. Mounjaro is a GLP-1 receptor agonist used for diabetes management, consistent with AmerisourceBergen's extensive portfolio of pharmaceutical products supplied to federal healthcare systems. This delivery order is part of AmerisourceBergen's significantly larger $999.99 billion DLA Troop Support Medical IDC through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, serves critical federal medical procurement needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's established relationship with the Defense Logistics Agency demonstrates its capability to meet federal procurement requirements across a broad spectrum of pharmaceutical products and medical supplies on a competitive basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.1k | 8/20/25 |